Rilmenidine

Rilmenidine
Clinical data
Trade names	Albarel
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	C02AC06 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Protein binding	7%
Metabolism	Minimal
Elimination half-life	8 hours
Excretion	Renal, unchanged
Identifiers
	IUPAC name N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;
CAS Number	54187-04-1 ;
PubChem CID	68712;
ChemSpider	61963 ;
UNII	P67IM25ID8;
ChEMBL	ChEMBL289480 ;
CompTox Dashboard (EPA)	DTXSID3045194 ;
ECHA InfoCard	100.053.638
Chemical and physical data
Formula	C10H16N2O
Molar mass	180.251 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O1CCN=C1NC(C2CC2)C3CC3;
	InChI InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12) ; Key:CQXADFVORZEARL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Rilmenidine is a prescription medication for the treatment of hypertension.^[1] It is taken orally and marketed under the brand names Albarel, Hyperium, Iterium and Tenaxum.

^ Remková A, Kratochvíl'ová H (August 2002). "Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension". Journal of Human Hypertension. 16 (8): 549–55. doi:10.1038/sj.jhh.1001427. PMID 12149660.

[pmid12149660-1] Remková A, Kratochvíl'ová H (August 2002). "Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension". Journal of Human Hypertension. 16 (8): 549–55. doi:10.1038/sj.jhh.1001427. PMID 12149660.

[1]